CA631321A - 3-oxygenated allopregnane-6,11-dione compounds - Google Patents

3-oxygenated allopregnane-6,11-dione compounds

Info

Publication number
CA631321A
CA631321A CA631321A CA631321DA CA631321A CA 631321 A CA631321 A CA 631321A CA 631321 A CA631321 A CA 631321A CA 631321D A CA631321D A CA 631321DA CA 631321 A CA631321 A CA 631321A
Authority
CA
Canada
Prior art keywords
allopregnane
oxygenated
dione compounds
dione
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA631321A
Inventor
Fried John
Arth Glen
E. Beyler Roger
H. Sarett Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Publication date
Application granted granted Critical
Publication of CA631321A publication Critical patent/CA631321A/en
Expired legal-status Critical Current

Links

CA631321A 3-oxygenated allopregnane-6,11-dione compounds Expired CA631321A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA631321T

Publications (1)

Publication Number Publication Date
CA631321A true CA631321A (en) 1961-11-21

Family

ID=35887461

Family Applications (1)

Application Number Title Priority Date Filing Date
CA631321A Expired CA631321A (en) 3-oxygenated allopregnane-6,11-dione compounds

Country Status (1)

Country Link
CA (1) CA631321A (en)

Similar Documents

Publication Publication Date Title
CA631321A (en) 3-oxygenated allopregnane-6,11-dione compounds
CA623267A (en) N-vinyl-x-alkyl-2-oxazolidinone compounds
CA618346A (en) Polyfluorocarbonyl compounds
CA620543A (en) 2-methyl-6-fluoro-1,4-pregnadienes
AU281621B2 (en) 3-substituted-13, 17-dialkyl-17-hydroxy
CA595839A (en) 16-substituted-pregnane-11,20-dione-3-acylate compounds
AU2315462A (en) 3-substituted-13, 17-dialkyl-17-hydroxy
AU259166B2 (en) 3, 8-diazabicyclo-(3, 2, 1)-octanes
CA625561A (en) 1-acetyl-6-methoxy-9-methyl-3,4,5,6,7,8,9,10-octahydronaphthalene
CA629026A (en) 4,7-diamino-n-aralkyl-2-aryl-6-pteridinecarboxamides
AU272093B2 (en) 2, 3-alkylene-tetrahydro-guinolines
AU272161B2 (en) 3,5 - dihalo - amino - benzylamines
AU270786B2 (en) 1, 4-dihydroxyanthraquinones
CA620171A (en) 4-pyridoxylamino-3-isoxazolidone compounds
CA630010A (en) Dodecahydrophenanthrene compounds
CA630597A (en) Chlorofluorophenoxy compounds
CA623561A (en) Dodecahydrophenanthrene compounds
CA612052A (en) 4-pyridoxylideneamino-3-isoxazolidone compounds
AU257520B2 (en) 3-phenyl-7-hydroxy-coumarin compounds
AU267803B2 (en) Gaunidine compounds
AU270521B2 (en) Hendecapeptide compounds
AU272351B2 (en) Pyridopyrimidinone compounds
CA621113A (en) Substituted amide-1,4-diacylpiperazine complexes
CA611891A (en) 3,3',5,5'-tetraalkyldiphenoquinones
CA598784A (en) 16-dimethylaminoethyl-pregnane-3-ol-11,20-dione compounds